Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...
MENOPAUSE and prostate patients will be some of the first to use the new NHS “online hospital” next year. The completely ...
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...
Over the past six years, patients and their surviving relatives have filed at least eight malpractice suits over allegedly ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...
A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...
Two Atlanta-area prostate cancer survivors are joining forces to share their stories in an effort to help others. Ernie ...